Method for diagnosing a disease state using ocular characteristics
View Patent ↗A method for diagnosing a disease state in a subject, including examining the subject's eyes in order to determine whether the subject exhibits one or more symptoms of the disease state. Symptoms of the disease state include altered ocular characteristics, such as pupil size, pupil motility, ocular blood vessel coloration, and strobe light cutoff frequency. By evaluating changes to ocular characteristics, a disease state can be diagnosed in a subject. In addition, the severity of the disease state also can be determined.
1. A method of diagnosing cyanide exposure of a subject, comprising the step of:
(a) determining whether the subject's ocular blood vessel coloration varies significantly from a normal ocular blood vessel coloration by:
(1) quantifying the subject's ocular blood vessel coloration; and
(2) comparing the quantity from said step (1) to a quantified normal vessel coloration.
2. The method of claim 1 , wherein the normal ocular blood vessel coloration of said step (a) is determined for each subject.
3. The method of claim 1 , wherein the normal ocular blood vessel coloration of said step (a) is determined as an average for a population to which the subject belongs.
4. The method of claim 1 , wherein the ocular blood vessels of said step (a) are venous vessels.
5. The method of claim 1 , wherein the ocular blood vessels of said step (a) are arterial vessels.
6. A method of diagnosing carbon monoxide exposure of a subject, comprising the step of:
(a) determining whether the subject's ocular blood vessel coloration varies significantly from a normal ocular blood vessel coloration by:
(1) quantifying the subject's ocular blood vessel coloration; and
(2) comparing the quantity from said step (1) to a quantified normal vessel coloration.
7. The method of claim 6 , wherein the normal ocular blood vessel coloration of said step (a) is determined for each subject.
8. The method of claim 6 , wherein the normal ocular blood vessel coloration of said step (a) is determined as an average for a population to which the subject belongs.
9. The method of claim 6 , wherein the ocular blood vessels of said step (a) are venous vessels.
10. The method of claim 6 , wherein the ocular blood vessels of said step (a) are arterial vessels.
11. A method of diagnosing botulinum toxin exposure of a subject, comprising the step of:
(a) determining whether the subject's strobe cutoff frequency varies significantly from a normal strobe cutoff frequency by:
(1) quantifying the subject's strobe cutoff frequency; and
(2) comparing the quantity from said step (a1) to a quantified normal strobe cutoff frequency.
12. The method of claim 11 , wherein the normal strobe cutoff frequency of said step (a) is determined for each subject.
13. The method of claim 11 , wherein the normal strobe cutoff frequency of said step (a) is determined as an average for a population to which the subject belongs.